75%)

At 1 year, signiﬁcant
reduction in number
of IPVs and limbs with
IPVs with addition of
SEPS; no signiﬁcant
difference in pain
(VAS), mobility,
cosmetic score, or QoL
(SF-36, AVVQ)
between groups

RCT

69 Patients
with varicose
veins (C2/C3)
and thigh
IPV without
SFJ re